Drugs for Hyperparathyroidism (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 124)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Calcium acetate |
Approved, Investigational |
Phase 4 |
|
62-54-4 |
|
Synonyms:
Acetate OF lime
Acetic acid OF lime
Acetic acid, calcium salt
Acetic acid, calcium salt (2:1)
Brown acetate OF lime
Brown acetic acid OF lime
Ca(oac)2
Calcio acetato
Calcium acetate
Calcium acetic acid
|
Calcium ethanoate
Calcium ethanoic acid
Calcium(II) acetate
Calcium(II) acetic acid
Gray acetate OF lime
Gray acetic acid OF lime
Lime acetate
Lime acetic acid
Lime pyrolignite
Phoslo
|
|
2 |
|
Sevelamer |
Approved |
Phase 4 |
|
52757-95-6 |
3085017 |
Synonyms:
RENAGEL
RENVELA
Sevelamer
|
Sévélamer
Sevelamero
Sevelamerum
|
|
3 |
|
Darbepoetin alfa |
Approved, Investigational |
Phase 4 |
|
209810-58-2 |
|
Synonyms:
ARANESP
ARANESP SURECLICK
Darbepoetin
DARBEPOETIN ALFA
Darbepoetin alfa,recombinant
Darbepoetina alfa
|
EPOETIN
ERYTHROPOIETIN PRECURSOR
KRN321
KRN-321
NESP
|
|
4 |
|
Benzocaine |
Approved, Investigational |
Phase 4 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
5 |
|
Tannic acid |
Approved |
Phase 4 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
6 |
|
Atorvastatin |
Approved |
Phase 4 |
|
134523-00-5 |
60823 |
Synonyms:
(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid
(3R,5R)-7-[2-(4-FLUOROPHENYL)-3-PHENYL-4-(PHENYLCARBAMOYL)-5-(PROPAN-2-YL)-1H-PYRROL-1-YL]-3,5-DIHYDROXYHEPTANOIC ACID
(R-(R*,r*))-2-(4-fluorophenyl)-b,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-b,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-b,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-b,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
7-[2-(4-FLUORO-phenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoate
7-[2-(4-FLUORO-phenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoIC ACID
Anhydrous, atorvastatin calcium
Atogal
Atorlip
Atorpic
ATORVASTATIN
Atorvastatin acid
Atorvastatin calcium
Atorvastatin calcium anhydrous
Atorvastatin calcium hydrate
Atorvastatin calcium trihydrate
Atorvastatin, calcium salt
Atorvastatina
Atorvastatine
Atorvastatinum
Calcium anhydrous, atorvastatin
Calcium hydrate, atorvastatin
Calcium salt atorvastatin
Calcium trihydrate, atorvastatin
Calcium, atorvastatin
|
Cardyl
Faboxim
Hipolixan
Hydrate, atorvastatin calcium
LCF872
Lipitor
Lipitor®
Lipotropic
Lipovastatinklonal
Liprimar
Liptonorm
Lowden
Normalip
PREVENCOR
Sincol
Sortis
Sotis
TAHOR
Torvacard
Torvast
Totalip
Tozalip
Trihydrate, atorvastatin calcium
Tulip
Vastina
Xanator
Xarator
Xavator
ZARATOR
Zurinel
|
|
7 |
|
Strontium ranelate |
Approved, Withdrawn |
Phase 4 |
|
135459-87-9 |
|
8 |
|
Zoledronic acid |
Approved |
Phase 4 |
|
118072-93-8 |
68740 |
Synonyms:
(1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonate
(1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonate
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
ácido zoledrónico
ACLASTA
Aclasta®|CGP-42446|CGP-42446A|Reclast®|zoledronate|Zometa®
ANHYDROUS ZOLEDRONIC ACID
CGP-42446
CGP-42446A
Novartis brand OF zoledronic acid
|
Reclast
ZERLINDA
ZOL
ZOL446
ZOLEDRONATE
Zoledronic acid
Zoledronic acid anhydrous
ZOLEDRONIC ACID HYDRATE
ZOLEDRONIC ACID MONOHYDRATE
ZOLEDRONIC ACID, ANHYDROUS
Zometa
Zometa Concentrate
|
|
9 |
|
Cinacalcet |
Approved |
Phase 4 |
|
226256-56-0 |
156419 |
Synonyms:
(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
(R)-a-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
(R)-Α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
073, AMG
1493, KRN
alpha-Methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphar)-hydrochloride
AMG 073
AMG-073
AMG-073|Mimpara®|Sensipar®
|
CINACALCET
Cinacalcet hydrochloride
CNC
Hydrochloride, cinacalcet
KRN1493
KRN-1493
Mimpara
N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine
Sensipar
|
|
10 |
|
Denosumab |
Approved |
Phase 4 |
|
615258-40-7 |
|
Synonyms:
AMG-162
Denosumab
PROLIA
PROLIA, RANMARK XGEVA
|
PROLIA, XGEVA
TK006
TK-006
XGEVA
|
|
11 |
|
Alfacalcidol |
Approved, Nutraceutical |
Phase 4 |
|
41294-56-8 |
5282181 |
Synonyms:
(5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-1a,3b-diol
(5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-1alpha,3beta-diol
(5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-1α,3β-diol
1 alpha-Hydroxycholecalciferol
1 alpha-Hydroxyvitamin D3
1a-Hydroxycholecalciferol
1a-Hydroxyvitamin D3
1a-Hydroxy-vitamin D3
1a-Hydroxyvitamin D3 / 1a-hydroxycholecalciferol
1alpha-Hydroxycholecalciferol
1alpha-Hydroxyvitamin D3
1alpha-Hydroxy-vitamin D3
1alpha-OHD3
1-alpha-Oxycholecalciferol
1-Hydroxycholecalciferol
1-Hydroxycholecalciferol, (1alpha,3alpha-(5Z,7E))-isomer
1-Hydroxycholecalciferol, (1beta)-(5Z)-isomer
1-Hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer
1-Hydroxycholecalciferol, aluminum salt
1Α-hydroxycholecalciferol
|
1Α-hydroxyvitamin D3
1Α-hydroxy-vitamin D3
1Α-hydroxyvitamin D3 / 1α-hydroxycholecalciferol
9,10-Secocholesta-5,7,10(19)-triene-1a,3b-diol
9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta-diol
9,10-Secocholesta-5,7,10(19)-triene-1α,3β-diol
Alfacalcidol
Alfacalcidolum
AlfaD
Alphacalcidol
Alsiodol
Bondiol
Doss brand OF alfacalcidol
Eenalfadrie
EinsAlpha
Etalpha
Oksidevit
One-Alpha
Un-alfa
|
|
12 |
|
Calcitriol |
Approved, Nutraceutical |
Phase 4 |
|
32222-06-3 |
5280453 |
Synonyms:
(1a,3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
(1alpha,3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
(1R,3S,5Z)-5-{2-[(1R,3AS,4E,7AR)-1-[(2R)-6-HYDROXY-6-METHYLHEPTAN-2-YL]-7A-METHYL-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXANE-1,3-DIOL
(1S,3R,5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene-1,3,25-triol
(1S,3R,5Z,7E)-9,10-Secocholesta-5,7,10-triene-1,3,25-triol
(1Α,3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol
(5Z,7E)-(1S,3R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
1 alpha, 25 Dihydroxy 20 epi vitamin D3
1 alpha, 25-Dihydroxy-20-epi-vitamin D3
1 alpha,25 Dihydroxycholecalciferol
1 alpha,25 Dihydroxyvitamin D3
1 alpha,25-Dihydroxycholecalciferol
1 alpha,25-Dihydroxyvitamin D3
1,25 Dihydroxy 20 epi vitamin D3
1,25 Dihydroxycholecalciferol
1,25 Dihydroxyvitamin D3
1,25(OH)2-20EPi-D3
1,25-DHCC
1,25-Dihydroxy-20-epi-vitamin D3
1,25-Dihydroxycholecalciferol
1,25-Dihydroxyvitamin D
1,25-Dihydroxyvitamin D3
1a,25(OH)2D3
1a,25-(OH)2D3
1a,25-Dihydroxycholecalciferol
1a,25-Dihydroxyvitamin D3
1a,25-Dihydroxyvitamin D3 / 1a,25-dihydroxycholecalciferol / calcitriol
1-a-25-Dihydroxyvitamin D3
1alpha,25(OH)2D3
1alpha,25-Dihydroxycholecalciferol
1alpha,25-Dihydroxyvitamin D3
1-alpha,25-Dihydroxyvitamin D3
1-alpha-25-Dihydroxyvitamin D3
1Α,25(OH)2D3
1Α,25-dihydroxycholecalciferol
1Α,25-dihydroxyvitamin D3
1Α,25-dihydroxyvitamin D3 / 1α,25-dihydroxycholecalciferol / calcitriol
1-Α-25-dihydroxyvitamin D3
20 Epi 1alpha,25 dihydroxycholecaliferol
20-Epi-1alpha,25-dihydroxycholecaliferol
25-Dihydroxycholecalciferol
5-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol
Abbott brand OF calcitriol
alpha,25-Dihydroxyvitamin D3, 1
Alphapharm brand OF calcitriol
Bocatriol
Calcijex
Calcijex®|calcitriol|Rocaltrol®
|
Calcitriol
Calcitriol abbott brand
Calcitriol alphapharm brand
Calcitriol cryopharma brand
Calcitriol galderma brand
Calcitriol gry brand
Calcitriol jenapharm brand
Calcitriol kyramed
Calcitriol kyramed brand
Calcitriol leo brand
Calcitriol medice brand
Calcitriol nefro
Calcitriol renacare brand
Calcitriol roche brand
Calcitriol-nefro
CalcitriolNefro
Calcitriolum
Cryopharma brand OF calcitriol
D3, 1 alpha,25-Dihydroxyvitamin
D3, 1,25-Dihydroxy-20-epi-vitamin
D3, 1,25-Dihydroxyvitamin
Decostriol
DIHYDROXYCHOLECALCIFEROL
DIHYDROXYVITAMIN D 3
Dihydroxyvitamin D3
Galderma brand OF calcitriol
Gry brand OF calcitriol
Hoffmann la roche brand OF calcitriol
Hoffmann-la roche brand OF calcitriol
Jenapharm brand OF calcitriol
KyraMed brand OF calcitriol
KyraMed, calcitriol
Leo brand OF calcitriol
Medice brand OF calcitriol
Osteotriol
RenaCare brand OF calcitriol
Renatriol
Ro 21-5535
RO-215535
RO-21-5535
Rocaltrol
Roche brand OF calcitriol
Silkis
Sitriol
Soltriol
Tirocal
Topitriol
Toptriol
VECTICAL
|
|
13 |
|
Vasodilator Agents |
|
Phase 4 |
|
|
|
14 |
|
Antimetabolites |
|
Phase 4 |
|
|
|
15 |
|
Hypolipidemic Agents |
|
Phase 4 |
|
|
|
16 |
|
Lipid Regulating Agents |
|
Phase 4 |
|
|
|
17 |
|
Hydroxycholecalciferols |
|
Phase 4 |
|
|
|
18 |
|
Chelating Agents |
|
Phase 4 |
|
|
|
19 |
|
Liver Extracts |
|
Phase 4 |
|
|
|
20 |
|
Anticholesteremic Agents |
|
Phase 4 |
|
|
|
21 |
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors |
|
Phase 4 |
|
|
|
22 |
|
Epoetin Alfa |
|
Phase 4 |
|
|
|
Synonyms:
BINOCRIT
EPO
EPOETIN ALFA
EPOGEN
|
EPREX
ERYTHROPOIETIN PRECURSOR
PROCRIT
|
|
23 |
|
Hematinics |
|
Phase 4 |
|
|
|
24 |
|
Chrysarobin |
|
Phase 4 |
|
|
|
25 |
|
Vasoconstrictor Agents |
|
Phase 4 |
|
|
|
26 |
|
1 alpha-hydroxyergocalciferol |
|
Phase 4 |
|
|
|
27 |
|
Dihydroxycholecalciferols |
|
Phase 4 |
|
|
|
28 |
|
Teriparatide |
Approved, Investigational |
Phase 3 |
|
52232-67-4 |
16133850 155817470 |
Synonyms:
FORSTEO
Forsteo®|Forteo®|PTH-(1-34) (human)
FORTEO
LY 333334
LY333334
LY-333334
PTH (1-34)
|
PTH 1-34
PTH134
Teriparatida
Teriparatide
Teriparatide recombinant human
ZT-034
|
|
29 |
|
Calcium carbonate |
Approved, Investigational |
Phase 3 |
|
471-34-1 |
|
Synonyms:
Aragonite
CaCO3
Calcio carbonato
Calcite
Calcium carbonate
Calcium carbonate (1:1)
Calcium carbonate, precipitated
Calcium carbonic acid
Calcium carbonic acid (1:1)
Calcium carbonic acid, precipitated
Calcium milk
Calciumcarbonat
Cal-sup
Carbonate calcium salt (1:1)
Carbonate de calcium
|
Carbonate, calcium
Carbonato de calcio
Carbonic acid calcium salt (1:1)
Carbonic acid de calcium
Chalk
e 170
Kalziumkarbonat
Kohlensaurer kalk
Limestone
Marble
Milk OF calcium
Precipitated calcium carbonate
Precipitated calcium carbonic acid
Vaterite
|
|
30 |
|
Amiloride |
Approved |
Phase 2, Phase 3 |
|
17440-83-4, 2016-88-8, 2609-46-3 |
16231 |
Synonyms:
3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide
Alphapharm brand OF amiloride hydrochloride
Amiclaran
Amidal
Amiduret trom
AMILAMONT
Amiloberag
Amilorid
Amilorida
Amilorida [INN-Spanish]
Amiloride
AMILORIDE HCL
amiloride HCl|Midamor®
Amiloride hydrochloride
AMILORIDE HYDROCHLORIDE DIHYDRATE
Amiloride hydrochloride hydrate
Amiloride hydrochloride, anhydrous
Amiloridum
Amiloridum [INN-Latin]
AMILOSPARE 5
Amipramidin
Amipramidine
Amipramizid
Amipramizide
|
Amiprazidine
AMORIDE
AMR
Amrad brand OF amiloride hydrochloride
Amyloride
Anhydrous amiloride hydrochloride
BERKAMIL
Berolina brand OF amiloride hydrochloride
Cahill may roberts brand OF amiloride hydrochloride
Douglas brand OF amiloride hydrochloride
Guanamprazin
Guanamprazine
Hydrochloride, amiloride
Hydrochloride, anhydrous amiloride
HYDRO-RIDE
Kaluril
Merck brand OF amiloride hydrochloride
Merck sharp and dohme brand OF amiloride hydrochloride
Midamor
Midoride
Modamide
N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide
Trom, amiduret
Trommsdorff brand OF amiloride hydrochloride
|
|
31 |
|
Eplerenone |
Approved |
Phase 2, Phase 3 |
|
107724-20-9 |
443872 |
Synonyms:
9,11-Epoxy-7-(methoxycarbonyl)-3-oxo-17-pregn-4-ene-21,17-carbolactone
Eplerenon
Eplerenona
EPLERENONE
Epoxymexrenone
|
Inspra
Inspra®|SC-66110
SC-66110
SC-6611O
|
|
32 |
|
Choline |
Approved, Nutraceutical |
Phase 3 |
|
62-49-7 |
305 |
Synonyms:
(2-Hydroxyethyl)trimethyl ammonium
(2-Hydroxyethyl)trimethylammonium
(2-HYDROXYETHYL)TRIMETHYLAZANIUM
(beta-Hydroxyethyl)trimethylammonium
2-HYDROXYETHYL-TRIMETHYL-AMMONIUM
2-HYDROXYETHYL-TRIMETHYL-AZANIUM
2-Hydroxy-N,N,N-trimethylethanaminium
2-Hydroxy-N,N,N-trimethyl-ethanaminium
Bilineurine
Biocolina
Biocoline
Bitartrate, choline
Bursine
Chloride, choline
CHOLINE
Choline bitartrate
Choline cation
Choline chloride
Choline citrate
Choline hydroxide
|
CHOLINE ion
Choline O sulfate
Choline O-sulfate
Cholinum
Citrate, choline
Fagine
Hepacholine
Hormocline
Hydroxide, choline
Lipotril
N,N,N-Trimethylethanolammonium
N,N,N-Trimethylethanol-ammonium
Neocolina
N-Trimethylethanolamine
O-Sulfate, choline
Paresan
Trimethylethanolamine
Vidine
Vitamin J
|
|
33 |
|
Maxacalcitol |
Investigational |
Phase 3 |
|
103909-75-7 |
6398761 |
Synonyms:
22-oxa-1α,25(OH)2D3|22-oxacalcitriol|OCT
|
|
|
34 |
|
Dermatologic Agents |
|
Phase 3 |
|
|
|
35 |
|
Protective Agents |
|
Phase 3 |
|
|
|
36 |
|
Antihypertensive Agents |
|
Phase 2, Phase 3 |
|
|
|
37 |
|
diuretics |
|
Phase 2, Phase 3 |
|
|
|
38 |
|
Sodium Channel Blockers |
|
Phase 2, Phase 3 |
|
|
|
39 |
|
Diuretics, Potassium Sparing |
|
Phase 2, Phase 3 |
|
|
|
40 |
|
Mineralocorticoids |
|
Phase 2, Phase 3 |
|
|
|
41 |
|
Mineralocorticoid Receptor Antagonists |
|
Phase 2, Phase 3 |
|
|
|
42 |
|
Pharmaceutical Solutions |
|
Phase 3 |
|
|
|
43 |
|
Nootropic Agents |
|
Phase 3 |
|
|
|
44 |
|
Gastrointestinal Agents |
|
Phase 3 |
|
|
|
45 |
|
Technetium Tc 99m Sestamibi |
|
Phase 3 |
|
|
|
46 |
|
Phytosterol |
|
Phase 3 |
|
|
|
47 |
|
Methylene blue |
Approved, Investigational |
Phase 1, Phase 2 |
|
61-73-4 |
6099 |
Synonyms:
3,7-BIS(DIMETHYLAMINO)PHENAZATHIONIUM CHLORIDE
aniline violet
Azul de metileno
BASIC BLUE 9
C.I. 52015
C.I. BASIC BLUE 9
Chlorure de méthylthioninium
CI 52015
CI-52015
Cloruro de metiltioninio
EHRLICH'S REAGENT III
LOWACRYL BLUE 9
METHYLENE BLUE
METHYLENE BLUE ANHYDROUS
METHYLENE BLUE TRIHYDRATE
|
METHYLENIUM CERULEUM
METHYLTHIONINE CHLORIDE
METHYLTHIONINE HCL
Methylthioninii chloridum
METHYLTHIONINIUM CHLORIDE
methylthioninium chloride Proveblue
NSC-215213
NSC-617593
PROVAYBLUE
SOLVENT BLUE 8
SWISS BLUE
tetrametylthionine chloride
TRX0014
UROLENE BLUE
VIB100
|
|
48 |
|
Racemethionine |
Approved, Experimental, Investigational, Nutraceutical |
Phase 2 |
|
59-51-8, 63-68-3, 348-67-4 |
6137 |
Synonyms:
(+-)-Methionine
(+/-)-2-amino-4-(methylmercapto)butyric acid
(2S)-2-Amino-4-(methylsulfanyl)butanoate
(2S)-2-Amino-4-(methylsulfanyl)butanoic acid
(2S)-2-Amino-4-(methylsulphanyl)butanoate
(2S)-2-Amino-4-(methylsulphanyl)butanoic acid
(2S,3R)-2-AMMONIO-3-HYDROXYBUTANOATE
(3R,3'r,6S)-4,5-DIDEHYDRO-5,6-dihydro-b,b-carotene-3,3'-diol
(3R,3'r,6S)-4,5-DIDEHYDRO-5,6-dihydro-BETA,BETA-carotene-3,3'-diol
(3R,3'r,6S)-4,5-DIDEHYDRO-5,6-dihydro-β,β-carotene-3,3'-diol
(L)-Methionine
(S)-(+)-Methionine
(S)-2-Amino-4-(methylthio)butanoate
(S)-2-Amino-4-(methylthio)-butanoate
(S)-2-Amino-4-(methylthio)butanoic acid
(S)-2-Amino-4-(methylthio)-butanoic acid
(S)-2-Amino-4-(methylthio)butyrate
(S)-2-Amino-4-(methylthio)butyric acid
(S)-Methionine
2-amino-4-(methylmercapto)Butyric acid
2-Amino-4-(methylsulfanyl)butanoate
2-Amino-4-(methylsulfanyl)butanoic acid
2-Amino-4-(methylsulphanyl)butanoate
2-Amino-4-(methylsulphanyl)butanoic acid
2-Amino-4-(methylthio)butanoate
2-Amino-4-(methylthio)butanoic acid
2-Amino-4-(methylthio)butyrate
2-amino-4-(methylthio)-Butyric acid
2-Amino-4-(methylthio)butyric acid
2-Amino-4-methylthiobutanoate
2-amino-4-Methylthiobutanoic acid
a-Amino-g-methylmercaptobutyrate
a-Amino-g-methylmercaptobutyric acid
Acimethin
alpha-Amino-alpha-aminobutyric acid
alpha-amino-gamma-(methylthio)Butyric acid
alpha-Amino-gamma-methylmercaptobutyrate
alpha-Amino-gamma-methylmercaptobutyric acid
Bo-xan
Cymethion
DL-2-amino-4-(methylthio)Butanoic acid
DL-2-amino-4-(methylthio)Butyric acid
DL-2-amino-4-(methylthio)-Butyric acid
DL-2-amino-4-Methylthiobutanoic acid
DL-Methionine
DL-Methioninum
e 161b
FEMA 3301
gamma-Methylthio-alpha-aminobutyrate
gamma-Methylthio-alpha-aminobutyric acid
g-Methylthio-a-aminobutyrate
g-Methylthio-a-aminobutyric acid
Hmet
|
H-Met-H
H-Met-OH
L(-)-Amino-alpha-amino-alpha-aminobutyric acid
L(-)-Amino-gamma-methylthiobutyric acid
L-(-)-Methionine
L-(−)-METHIONINE
L-2-Amino-4-(methylthio)butyric acid
L-2-Amino-4methylthiobutyrate
L-2-Amino-4methylthiobutyric acid
L-2-Amino-4-methylthiobutyric acid
L-a-Amino-g-methylmercaptobutyrate
L-a-Amino-g-methylmercaptobutyric acid
L-a-Amino-g-methylthiobutyrate
L-a-Amino-g-methylthiobutyric acid
L-alpha-Amino-gamma-methylmercaptobutyrate
L-alpha-Amino-gamma-methylmercaptobutyric acid
L-alpha-Amino-gamma-methylthiobutyrate
L-alpha-Amino-gamma-methylthiobutyric acid
L-gamma-Methylthio-alpha-aminobutyric acid
Liquimeth
L-Isomer methionine
L-MET
L-Methionin
L-Methionine
L-Methionine Z
L-Methioninum
L-Α-amino-γ-methylmercaptobutyrate
L-Α-amino-γ-methylmercaptobutyric acid
M
Mepron
Met
Methilanin
Methionin
Methionine
Methionine, L isomer
Methionine, L-isomer
Methioninum
Metionina
Neo-methidin
NSC-22946
Padameth
Pedameth
Poly-L-methionine
Polymethionine
Racemethionine
Racemethionine, usan
S-Methionine
S-Methyl-L-homocysteine
Toxin war
Xanthophyll
Α-amino-γ-methylmercaptobutyrate
Α-amino-γ-methylmercaptobutyric acid
|
|
49 |
|
Carbon-11 methionine |
|
Phase 2 |
|
|
|
50 |
|
Fluorodeoxyglucose F18 |
|
Phase 2 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 306)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Providing Intravenous Paricalcitol Treatment to the Sick and Poor Chronic Hemodialysis Patients With Severe Secondary Hyperparathyroidism Resistant to Existing Vitamin D Analogs |
Unknown status |
NCT03023748 |
Phase 4 |
Intravenous Paricalcitol |
2 |
An Open-label Study of Combination of Cinacalcet and Active Vitamin D Analogue in the Management of Severe Secondary Hyperparathyroidism in Haemodialysis Patients |
Unknown status |
NCT02338934 |
Phase 4 |
Combination Cinacalcet with Vitamin D analogue |
3 |
Improving the Sensitivity of Sestamibi SPECT-CT Parathyroid Scan With Calcitonin Pre-treatment for Primary Hyperparathyroidism |
Unknown status |
NCT03935984 |
Phase 4 |
Calcitonin |
4 |
A Randomized Study to Evaluate the Effects of Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease (CKD) Receiving Hemodialysis |
Completed |
NCT00379899 |
Phase 4 |
cinacalcet |
5 |
Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Renal Transplantation. |
Completed |
NCT01939977 |
Phase 4 |
Paricalcitol;Calcifediol |
6 |
Randomized Trial to Evaluate the Efficacy and Safety of Cinacalcet Treatment in Combination With Low Dose Vitamin D for the Treatment of Subjects With Secondary Hyperparathyroidism (SHPT) Recently Initiating Hemodialysis |
Completed |
NCT00803712 |
Phase 4 |
Cinacalcet;Vitamin D |
7 |
A Phase 4, Multi-Center, Open-Label, Randomized Study to Determine Clinically Appropriate Doses of Hectorol® Capsules When Converting From Hectorol® Injection for the Treatment of SHPT in Stage 5 CKD Subjects on Hemodialysis |
Completed |
NCT00418600 |
Phase 4 |
Hectorol® (doxercalciferol capsules);doxercalciferol capsules, Hectorol®;doxercalciferol capsules, Hectorol® capsules |
8 |
The Study of Efficacy and Safety of Calcium Sensing Receptor in Chronic Dialysis Patients |
Completed |
NCT02056730 |
Phase 4 |
calcium sensing receptor agonist |
9 |
A Phase 4, Multi Center, Open-Label, Randomized Study to Determine Clinically Appropriate Doses of Hectorol® (Doxercalciferol Capsules) When Converting From Zemplar® (Paricalcitol Injection) for the Treatment of Secondary Hyperparathyroidism in Stage 5 Chronic Kidney Disease (CKD) Subjects on Hemodialysis. |
Completed |
NCT00463021 |
Phase 4 |
Hectorol (doxercalciferol capsules);Zemplar (paricalcitol injection) |
10 |
A Randomized , Open-Label, Cross-over, Pharmacokinetic Study of Doxercalciferol and Paricalcitol Following Multiple Intravenous Injections in Chronic Kidney Disease Subjects on Hemodialysis |
Completed |
NCT00454350 |
Phase 4 |
Hectorol (doxercalciferol injection);Zemplar (Paricalcitol injection) |
11 |
A Study To Assess Achievement of NKF K/DOQI Targets Using Sensipar (Cinacalcet) in Australian Subjects With End Stage Renal Disease (ESRD) Who Are Being Treated With Aranesp for Anaemia Management |
Completed |
NCT00431496 |
Phase 4 |
Cinacalcet |
12 |
A Phase 4 Randomized Multicenter Open Label Trial of Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3 or 4 Ckd Patients With Secondary Hyperparathyroidism |
Completed |
NCT00823303 |
Phase 4 |
Paricalcitol;Calcitriol |
13 |
Effect of Doxercalciferol on Endothelial Cell Function in End Stage Renal Disease |
Completed |
NCT00528788 |
Phase 4 |
doxercalciferol |
14 |
Prospective, Non-randomized, Multicenter Study to Assess the Efficacy and Safety of Oral or Intravenous Paricalcitol Administered Over 6 Months to Patients With Secondary Hyperparathyroidism on Dialysis |
Completed |
NCT00537979 |
Phase 4 |
Paricalcitol injection;Paricalcitol capsules |
15 |
A Multi-center Study Evaluating Efficacy and Safety of Cinacalcet Hydrochloride(HCL) in Calcium, Phosphorus and Intact Parathyroid Hormone(iPTH) Serum Levels in Chinese Chronic Kidney Disease(CKD) Hemodialysis(HD) Patients With Mild, Moderate and Severe Secondary Hyperparathyroidism(SHPT) |
Completed |
NCT03123406 |
Phase 4 |
Cinacalcet HCl |
16 |
Effect of Cinacalcet Treatment on Vascular Arterial Stiffness Among Peritoneal Dialysis Patients With Secondary Hyperparathyroidism |
Completed |
NCT01143987 |
Phase 4 |
Cinacalcet |
17 |
Efficacy of a Calcimimetic (Cinacalcet) in the Long Term Control of Patients With Primary Hyperparathyroidism |
Completed |
NCT02417389 |
Phase 4 |
cinacalcet;Alendronate |
18 |
Trial to Optimize Mineral Outcomes in End Stage Renal Disease (ESRD) Patients |
Completed |
NCT01100723 |
Phase 4 |
|
19 |
Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis |
Completed |
NCT00053547 |
Phase 4 |
paricalcitol injection |
20 |
Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism |
Completed |
NCT00132431 |
Phase 4 |
Sensipar |
21 |
An Assessment of the Calcimimetic Agent AMG 073 for the Treatment of Subjects With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism. |
Completed |
NCT00037518 |
Phase 4 |
AMG 073 |
22 |
An Open-Label, Repeated-Dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Oral CTAP101 Capsules, Immediate- Release (IR) Calcifediol, High-Dose Cholecalciferol, and Paricalcitol Plus Low-Dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency |
Completed |
NCT03588884 |
Phase 4 |
Calcifediol Oral Capsule;Calcifediol Oral Product;Cholecalciferol;Paricalcitol Oral Capsule |
23 |
ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism: A Comparison of Sensipar® and Low Dose Vitamin D vs. Escalating Doses of Vitamin D Alone |
Completed |
NCT00135304 |
Phase 4 |
Sensipar®;Vitamin D |
24 |
A Phase IV, Single-Center, Active-Controlled Cross-Over Pilot Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium |
Completed |
NCT00073710 |
Phase 4 |
Zemplar;Calcijex |
25 |
Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral Density |
Completed |
NCT01025128 |
Phase 4 |
25 OH vitamin D |
26 |
Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients: A Randomized Controlled Trial |
Completed |
NCT03182699 |
Phase 4 |
|
27 |
A Phase 4, Single-Center, Open-Label, Randomized, Active-Controlled, Cross-over Pilot Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in CKD Stage 5 Subjects on Hemodialysis |
Completed |
NCT00257920 |
Phase 4 |
Zemplar® injection;Hectorol® injection |
28 |
Initial Dosing of Paricalcitol Based on iPTH Parathyroid Hormone Levels in Hemodialysis Patients With Secondary Hyperparathyroidism |
Completed |
NCT00307840 |
Phase 4 |
paricalcitol |
29 |
Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity |
Completed |
NCT00288873 |
Phase 4 |
Ergocalciferol;Cholecalciferol |
30 |
CARE-2 (Calcium Acetate (PhosLo®)/Sevelamer(Renagel®) Evaluation Study 2) |
Completed |
NCT00211939 |
Phase 4 |
calcium acetate;sevelamer;atorvastatin |
31 |
Response of Secondary Hyperparathyroidism to Paricalcitol Versus Ergocalciferol in Patients With Stage 3 and 4 Chronic Kidney Disease With Vitamin D Deficiency: a Randomized Controlled Trial |
Completed |
NCT00958451 |
Phase 4 |
Paricalcitol;Ergocalciferol |
32 |
A Randomized Trial Comparing Pulse Calcitriol and Alfacalcidol for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients |
Completed |
NCT01115543 |
Phase 4 |
alfacalcidol and calcitriol |
33 |
A Phase 4, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Study to Assess the Efficacy and Safety of Doxercalciferol Capsules in Vitamin D-replete Subjects With Chronic Kidney Disease (CKD) Stages 3 or 4 With Secondary Hyperparathyroidism (SHPT). |
Completed |
NCT00123461 |
Phase 4 |
Hectorol (doxercalciferol capsules), 0.5mcg |
34 |
The IMPACT SHPT Study: Study to Evaluate the Improved Management of iPTH With Paricalcitol-centered Therapy vs. Cinacalcet Therapy With Low-dose Vitamin D in Hemodialysis Patients With Secondary Hyperparathyroidism |
Completed |
NCT00977080 |
Phase 4 |
Paricalcitol;Cinacalcet |
35 |
Effectiveness and Safety of a 6-Month Treatment With IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose |
Completed |
NCT00891813 |
Phase 4 |
Zemplar (paricalcitol) |
36 |
Phase 4 Study of Cinacalcet Efficacy in Combination With Vitamin D for the Treatment of Secondary Hyperparathyroidism in Peritoneal Dialysis Patients |
Completed |
NCT01101113 |
Phase 4 |
cinacalcet;control |
37 |
Comparison of Medical Therapy (Oral Cinacalcet) Versus Surgical Therapy (Total Parathyroidectomy) on Vascular/Valvular Calcification in Chronic Peritoneal Dialysis Patients With Secondary Hyperparathyroidism - A Pilot Randomized Study |
Completed |
NCT01447368 |
Phase 4 |
Cinacalcet |
38 |
Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium- and Bone Metabolism After Successful Surgery? - Part I |
Completed |
NCT01222026 |
Phase 4 |
Strontium Ranelate + Ca/Vitamin-D;Placebo |
39 |
A Prospective, Non-randomised, Single-arm, Open-Label Pilot Clinical Study Evaluating the Effect of PTH Lowering on Erythropoietin Consumption in Calcitriol-Resistant Patients |
Completed |
NCT01506947 |
Phase 4 |
Paricalcitol;Darbepoetin alfa |
40 |
Randomized Controlled Trial of Vitamin D Repletion Regimens in Primary Hyperparathyroidism |
Completed |
NCT01306656 |
Phase 4 |
10,000 IU Vitamin D3 |
41 |
A Prospective, Randomized Trial to Compare Subtotal Parathyroidectomy Versus Cinacalcet in the Treatment of Persistent Secondary Hyperparathyroidism Post Renal Transplantation |
Completed |
NCT01178450 |
Phase 4 |
Cinacalcet |
42 |
A Multicenter, Randomized, Open Label Study to Compare the Efficacy of Cinacalcet Versus Traditional Vitamin D Therapy for Management of Secondary Hyperparathyroidism Among Subjects Undergoing Hemodialysis |
Completed |
NCT01181531 |
Phase 4 |
Traditional Vitamin D Therapy;Cinacalcet |
43 |
Evaluation of a Parathyroid Hormone Suppression Test With Cinacalcet. Comparison: 1- With the Results of the Intravenous Calcium Suppression Test in Healthy Controls; 2- Between Healthy Controls and Patients With Primary Hyperparathyroidism. |
Completed |
NCT01103206 |
Phase 4 |
cinacalcet;cinacalcet dose 1;cinacalcet dose 2 |
44 |
A Randomized Trial Comparing an Integrated Care Approach Using Electronic Cinacalcet Adherence Data Versus Usual Care to Improve Secondary Hyperparathyroidism in Hemodialysis Patients |
Completed |
NCT01573520 |
Phase 4 |
|
45 |
Management of Osteoporosis in Patients With Primary Hyperparathyroidism |
Enrolling by invitation |
NCT04085419 |
Phase 4 |
Denosumab 60 MG/ML Prefilled Syringe [Prolia];Zoledronic Acid |
46 |
Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects |
Terminated |
NCT00664430 |
Phase 4 |
Calcitriol;Paricalcitol |
47 |
Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney |
Terminated |
NCT00646282 |
Phase 4 |
doxercalciferol |
48 |
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis |
Terminated |
NCT00446329 |
Phase 4 |
cinacalcet |
49 |
The Efficacy of 1,25 Dihydroxycholecalciferol on the Cardiovascular System in Patients With Renal Dysfunction |
Terminated |
NCT00175149 |
Phase 4 |
Alfacalcidiol |
50 |
A Randomized, Prospective, Cross-Over Study of Calcitriol vs. Paricalcitol in the Treatment of Mineral and Bone Disease in Hemodialysis Patients |
Terminated |
NCT01725113 |
Phase 4 |
Calcitriol;Paricalcitol |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Calcitriol
Cod Liver Oil
Dihydrotachysterol
|
Doxercalciferol
paricalcitol
|
|